Discovery of Dual Inhibitors of the Immune Cell PI3Ks p110δ and p110γ: a Prototype for New Anti-inflammatory Drugs
- 25 February 2010
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 17 (2) , 123-134
- https://doi.org/10.1016/j.chembiol.2010.01.010
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitorsNature Chemical Biology, 2010
- Phosphoinositide 3-Kinases γ and δ, Linkers of Coordinate C5a Receptor-Fcγ Receptor Activation and Immune Complex-induced InflammationPublished by Elsevier ,2008
- PI3Kgamma (PI3Kγ) is essential for efficient induction of CXCR3 on activated T cellsBlood, 2008
- A membrane capture assay for lipid kinase activityNature Protocols, 2007
- Selective glucocorticoid receptor agonists (SEGRAs): Novel ligands with an improved therapeutic indexMolecular and Cellular Endocrinology, 2007
- The PI3K‐Akt pathway promotes microtubule stabilization in migrating fibroblastsGenes to Cells, 2007
- Monocyte p110α phosphatidylinositol 3-kinase regulates phagocytosis, the phagocyte oxidase, and cytokine productionJournal of Leukocyte Biology, 2007
- A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin SignalingCell, 2006
- Selective role of PI3Kδ in neutrophil inflammatory responsesBiochemical and Biophysical Research Communications, 2003
- Leukotrienes in the pathogenesis of NSAID-induced gastric and intestinal mucosal damageInflammation Research, 1993